海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Clinical trial to determinate viral load in seminal fluid in HIV-positive patients without previous treatment
- HIV-1 infection MedDRA version: 17.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 10021881 - Infections and infestations MedDRA version: 17.1 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Spain
- 2014-12-10
Authorised
- Invloed van UDCA op fecale galzoutensamenstelling van IBD patiënten: piloot studie.
- Crohn's disease or colitis ulcerosa MedDRA version: 17.1 Level: PT Classification code 10009900 Term: Colitis ulcerative System Organ Class: 10017947 - Gastrointestinal disorders MedDRA version: 17.1 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Belgium
- 2014-09-26
Authorised
- Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib
- Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia / Castration-Resistant Prostate Cancer;Therapeutic area: Diseases [C] - Cancer [C04]
- Poland
- 2015-09-08
Authorised
- VAC-3S study in patients infected by HIV and controlled with an antiretroviral treatment who rose their immune response in study study IVVAC-3S/P1
- Chronically infected HIV-1 patients under viral control on Anti-Retroviral therapy. MedDRA version: 18.0 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- France
- 2015-06-23
Authorised
- Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary Tract
- evaluation of the effectiveness of antimicrobial prophylaxis in infants with vesico-ureteral reflux grade III-V, started before the first symptomatic infection MedDRA version: 16.0 Level: LLT Classification code 10047371 Term: Vesicoureteral reflux System Organ Class: 100000004857 ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Belgium, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Serbia, Spain, Switzerland, Turkey, United Kingdom
- 2013-06-07
Authorised
- Pilot study of Rituximab for the treatment of fatigue in PBC
- Severe fatigue in Primary Biliary Cirrhosis br>MedDRA version: 18.0 Level: PT Classification code 10004661 Term: Biliary cirrhosis primary System Organ Class: 10019805 - Hepatobiliary disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- United Kingdom
- 2012-07-04
Authorised
- A diminished concentrating ability of the kidneys due to lithium prescription: how many and whom is affected?
- lithium-induced urinary concentrating defects (nephrogenic diabetes insipidus) MedDRA version: 15.0 Level: LLT Classification code 10050501 Term: Lithium toxicity System Organ Class: 10022117 - Injury, poisoning and procedural complications MedDRA version: 15.0 Level: LLT Classification code 10012600 Term: Diabetes insipidus nephrogenic System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Netherlands
- 2012-09-06
Authorised
- The use of Tachosil as sealant in the prevention of lymphorrea after surgical removal of lymph nodes for vulvar cancer: a clinical controlled prospective trial
- lymphedema after groin lymphadenectomy in patients with vulvar cancer MedDRA version: 14.1 Level: LLT Classification code 10025233 Term: Lymphedema System Organ Class: 10047065 - Vascular disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Italy
- 2012-06-18
Authorised
- Treatment protocol of the second international study for hemophagoocytic lymphohistiocytosis (HLH) - HLH-2004
- Hemophagocytic lymphohistiocytosis (HLH) br>MedDRA version: 14.1 Level: PT Classification code 10049646 Term: Lymphohistiocytosis System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Italy
- 2012-03-05
Authorised
- Experimental study in humans to evaluate the efficacy and safety of blood products rich in proteins for the treatment of anal fistulas in Crohn's patients without subsidiary drug treatment.
- Perianal fistulas in Crohn's Disease Patients br>MedDRA version: 14.1 Level: PT Classification code 10002156 Term: Anal fistula System Organ Class: 10017947 - Gastrointestinal disorders MedDRA version: 14.1 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Spain
- 2012-02-15
Authorised
- Experimental study in humans to evaluate the efficacy and safety of blood products rich in proteins for the treatment of anal fistulas in Crohn's patients
- Perianal fistulas in Crohn's Disease Patients br>MedDRA version: 14.1 Level: LLT Classification code 10068659 Term: Perianal fistula System Organ Class: 10017947 - Gastrointestinal disorders MedDRA version: 14.1 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Spain
- 2012-02-15
Authorised
- The effect of the drug acetazolamide on excessive urine production due to a diminished concentrating ability of the kidney as a result of the use of lithium in patients with an affective disorder: a pilot study
- lithium-induced nephrogenic diabetes insipidus MedDRA version: 14.1 Level: LLT Classification code 10012600 Term: Diabetes insipidus nephrogenic System Organ Class: 10038359 - Renal and urinary disorders MedDRA version: 14.1 Level: LLT Classification code 10050501 Term: Lithium toxicity System Organ Class: 10022117 - Injury, poisoning and procedural complications ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Netherlands
- 2012-02-08
Authorised
- This open label trial will recruit patients with HIV who are already receiving anti-HIV treatment which includes a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) and emtricitabine/tenofovir disoproxil fumurate (Truvada). Patients will be randomised to either remain on the same anti-HIV drugs as prior to the study (namely consisting of NNRtI and Truvada) or switch to receive an investigational single tablet regimen (EVG/COBI/FTC/TDF) which contains 2 experimental drugs (EVG and COBI).
- Human Immunodeficiency Virus (HIV-1) Infections MedDRA version: 14.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Australia, Austria, Canada, Germany, Italy, Puerto Rico, Spain, United Kingdom, United States
- 2011-11-21
Authorised
- A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients with Moderately to Severely Active Crohn’s Disease
- Moderately to severely active Crohn's disease MedDRA version: 20.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Croatia, Czech Republic, Denmark, European Union, Germany, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Spain, United Kingdom, United States
- 2011-05-26
Authorised
- The degradation and elimination of Infliximab
- Inflammatory bowel disease (Ulcerative Colitis, Crohn's disease) MedDRA version: 17.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders MedDRA version: 17.0 Level: LLT Classification code 10045365 Term: Ulcerative colitis System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Austria
- 2013-11-07
Authorised
- Phase II study of crizotinib and Fluvestrant in lobular breast cancer or diffuse gastric cancer
- Patients with histological confirmation of E-cadherin negative, previously treated advanced lobular breast cancer or diffuse gastric cancer;Therapeutic area: Diseases [C] - Cancer [C04]
- United Kingdom
- 2018-06-21
Authorised
- Feasibility and effects of subcutaneously given combination of dexmedetomidine and ketamine in ALS patients receiving palliative care
- Amyotrophic lateral sclerosis (ALS) br>MedDRA version: 20.1 Level: LLT Classification code 10036704 Term: Primary lateral sclerosis System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Finland
- 2018-05-08
Authorised
- Efecto de la Infusión Intracoronaria de Células Progenitoras de Médula Ósea sobre la Regeneración Miocárdica en Pacientes con Miocardiopatía Dilatada. Estudio Cínico-Biológico. Effects of intracoronary infusion of bone marrow-derived progenitor cells on myocardial regeneration in patients with non-ischemic dilated cardiomyophathy. A clinico-biological study
- Miocardiopatía dilatada de origen idiopático Idiopathic Dilated Cardiomyopathy MedDRA version: 9.1 Level: LLT Classification code 10059868 Term: Non-ischemic dilated cardiomyopathy
- Spain
- 2007-09-11
Authorised
- Whole liver iron overload measured by the biosusceptometer Magnetic Iron Detector (MID) in thalassemia and MDS patients treated with deferasirox - ND
- Patients with diagnosis of thalassemia major with iron overload or regularly transfused MDS patients (Low/Intermediate-1 IPSS risk and 1 year life expectancy) MedDRA version: 9.1 Level: LLT Classification code 10010329 Term: Congenital anaemia
- Italy
- 2009-04-23
Authorised
- A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Crohn?s Disease Estudio multicéntrico, ciego, controlado con placebo, aleatorizado, de fase 3, sobre la inducción y el mantenimiento de la respuesta clínica y la remisión con MLN0002 en pacientes con enfermedad de Crohn moderada o grave.
- Moderate to Severe Crohn's Disease Enfermedad de Crohn moderada o grave MedDRA version: 9.1 Level: LLT Classification code 10013099 Term: Disease Crohns ;Moderate to Severe Crohn's Disease Enfermedad de Crohn moderada o grave MedDRA version: 9.1 Level: LLT Classification code 10013099 Term: Disease Crohns
- Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Malta, Netherlands, Portugal, Slovakia, Spain, Sweden, United Kingdom
- 2008-10-24
